Results 11 to 20 of about 2,564 (175)

Remimazolam Ameliorates Autistic‐Like Behaviors via Suppression of Ferroptosis in VTA Dopaminergic Neurons in a Mouse Model of ASD

open access: yesAdvanced Science
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, characterized by social dysfunction and stereotypic behavior, with the neuronal excitation/inhibition (E/I) imbalance as an underlying mechanism.
Yuxin Zhang   +7 more
doaj   +2 more sources

Anesthesia Management of a Liver Transplant Recipient with Remimazolam

open access: yesCase Reports in Anesthesiology, 2023
Background. Intraoperative anesthetic requirements might be altered due to the modulated metabolic function in living donor liver transplant recipients. Remimazolam may provide appropriate anesthesia in patients with cirrhosis.
Takashi Kawasaki   +2 more
doaj   +2 more sources

Postoperative Heart Failure with Preserved Ejection Fraction Induced by Flumazenil Administered for Remimazolam Antagonism

open access: yesCase Reports in Anesthesiology, 2022
Remimazolam is an ultrashort-acting benzodiazepine intravenous anesthetic characterized by rapid awakening after anesthesia. However, the method for administering remimazolam in clinical practice remains unclear.
Keito Koh   +5 more
doaj   +2 more sources

Comparison of Remimazolam and Midazolam for Sedation During Endoscopic Retrograde Cholangiopancreatography‐Related Procedures

open access: yesDEN Open
Objectives Remimazolam is an ultra‐short‐acting benzodiazepine recently approved for endoscopic procedures in Japan as a sedative agent.
Yuki Tanisaka   +7 more
doaj   +2 more sources

Mapping the Clinical Evidence on Remimazolam in Anaesthesia: A Protocol for a Scoping Review. [PDF]

open access: yesActa Anaesthesiol Scand
ABSTRACT Background Remimazolam is a recently introduced benzodiazepine used for procedural sedation and general anaesthesia. Its pharmacokinetic profile, including rapid metabolism and predictable recovery, has generated interest in its potential advantages compared with traditional sedatives such as midazolam and propofol.
Nilsson EHVS, Abood I, Møller AM.
europepmc   +2 more sources

Treatment-resistant hiccups during general anesthesia possibly caused by remimazolam: a case report

open access: yesJA Clinical Reports
Background Previous reports have described hiccups during general anesthesia that were possibly induced by drugs, including benzodiazepines. However, there are few reports of hiccups caused by remimazolam.
Miku Sakurai   +6 more
doaj   +2 more sources

Remimazolam-induced intracellular calcium elevation.

open access: yes, 2022
(A) An example of a typical remimazolam-induced intracellular calcium elevation time series in HUVECs. Approximately one min after the administration of 300 μM remimazolam, an increase in the fluorescence intensity of Fluo-4 was observed, indicating that
Soma Noguchi (12029730)   +8 more
core   +1 more source

Remimazolam-induced intracellular calcium elevation in HEK293 cells.

open access: yes, 2022
(A) Remimazolam at a concentration greater than or equal to 300 μM significantly induced the elevation of intracellular calcium in a dose-dependent manner in HEK293 cells. (n = 3–5, * p (TIF)
Soma Noguchi (12029730)   +8 more
core   +1 more source

Clinical Application and Research Progress of Remimazolam for Pediatric Patients

open access: yesDrug Design, Development and Therapy
Chen Bai, Mingcan Xu, Yan Guo, Yanwu Jin, Xin Zhao Department of Anesthesiology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of ChinaCorrespondence: Yanwu Jin; Xin Zhao, Department of ...
Chen Bai, Yanwu Jin, Xin Zhao
exaly   +2 more sources

Remimazolam-induced intracellular calcium elevation in SHSY-5Y cells and HUVECs.

open access: yes, 2022
(A) Remimazolam at a concentration greater than or equal to 300 μM significantly induced the elevation of intracellular calcium in a dose-dependent manner in SHSY-5Y cells (n = 3–7, * p < 0.05, compared to control, one-way ANOVA followed by Dunnett’s ...
Soma Noguchi (12029730)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy